BridgeBio Pharma Inc insider trades
as of filings through Nov 3, 2026
- Bought
- $0
- 0 trades, 0 insiders
- Sold
- $837K
- 2 trades, 2 insiders
- Net
- −$837K
- since Sep 21, 2026
- Under 10b5-1 plans
- 2
- of 2 sales
FiledStockInsiderSideValueSharesAvg priceTraded
- Filed Nov 3, 4:14 PM (the Form 4 at the SEC), traded Oct 30 · 4d late to fileBBIOSoldMaricel Apuli · Chief Accounting OfficerPlan$146K
- Filed Sep 21, 6:21 PM (the Form 4 at the SEC), traded Sep 17 · 4d late to fileBBIOSoldNeil Kumar · Chief Executive Officer, DirectorPlan$691K
More on BBIO
BBIO against its rivals
No comparison pages for BBIO.